Topics

Videos

In an interview with Pharma Commerce editor Nicholas Saraceno, Peter Ax, UpScriptHealth’s founder and CEO, discusses how patients are affected by these supply chain bottlenecks, along with ways to mitigate these complications.

The Relationship Between Patients and Drug Shortages 

Articles

Why these programs require a hybrid approach that combines technology and human connection.

The State of Patient Support Services in Today’s Landscape 

An economic evaluation study assesses these costs by therapeutic class, while identifying trends in pharma R&D intensity over time. 

Determining Drug Development Costs in the United States

An observational, retrospective cohort study undergoes this investigation in individuals 24 years of age or older. 

Comparing Bariatric Metabolic Surgery, Glucagon-Like Peptide-1 Receptor Agonists Mortality Among Patients with Obesity and Diabetes 

A cross-sectional study evaluates the difference in clinical outcomes and demographics between pediatric RSV patients during these multiple timeframes. 

Analyzing the Effects of Respiratory Syncytial Virus Pre- and Post-Pandemic

A cross-sectional audit study determines how racial and ethnic disparities—among English, Mandarin, and Spanish-speaking patients—can impact access.

Barriers Encountered by Patients While Making Cancer Care Clinic Appointments

A longitudinal observational study examined whether the program was related to access to hospital-based services, while determining if that association differs by hospital ownership.

The Association Between 340B Program Involvement and Availability of Hospital Services

A retrospective study investigates whether use of these portals can be defined by clinical and sociodemographic data.

Differences in Patient Portal Engagement Among Hypertension Patients

The Hopewell facility—which will serve as the CDMO’s North American hub—is expected to help accelerate the cell and gene therapy delivery process. 

ProBio Opens New Viral Vector Production Plant in the Garden State

In an interview with Pharma Commerce Editor Nicholas Saraceno, Fran Gregory, PharmD, Vice President of Emerging Therapies, Cardinal Health, discusses ways that changes made to reimbursement models are affecting patient therapies in the biosimilar space. 